Brief: China Regenerative Medicine International Says Unit Gets Nod To Set Up Shenzhen Tissue Engineering Laboratory
15/08/2018 14:46
Aug 15 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* ANNOUNCES APPROVAL FOR ESTABLISHMENT OF SHENZHEN TISSUE
ENGINEERING LABORATORY BY A UNIT
* CHINA REGENERATIVE MEDICINE INTERNATIONAL-UNIT GETS
SHENZHEN
DEVELOPMENT AND REFORM COMMISSION'S NOD TO SET UP SHENZHEN
TISSUE ENGINEERING LABORATORY
Source text for Eikon: urn:newsml:reuters.com:*:nHKS6JQwSV
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital